Nanotechnology Breath Test Could Help ID Gastric CA Earlier

This article originally appeared here.
Share this content:
Nanotechnology Breath Test Could Help ID Gastric CA Earlier
Nanotechnology Breath Test Could Help ID Gastric CA Earlier

(HealthDay News) -- A novel technology senses small changes in the levels of particular compounds in exhaled breath, and accurately identifies changes that signal the development of gastric cancer, according to a study published online April 13 in Gut.

The new test uses nanotechnology that analyzes a set of atoms called nanoarrays. In this case, the array includes atoms from breath samples and the computer looks for the amount of specific compounds that are linked to gastric cancer. Nanoarray analysis is accurate, simple, and inexpensive, the researchers said.

Christine Metz, Ph.D., director of the laboratory of medicinal biochemistry at the Feinstein Institute for Medical Research in Manhasset, N.Y., and colleagues collected two breath samples from 484 people, 99 of whom had been diagnosed with gastric cancer but had not yet had chemotherapy or radiation treatments. The patients were asked about their smoking and drinking habits and tested for infection with Helicobacter pylori. The first breath sample was analyzed using a technique that measures the various organic compounds in exhaled breath. The second sample was analyzed using a nanoarray.

The patterns identified using nanoarray technology accurately distinguished the different precancerous stages, identifying patients at low and high risk for developing gastric cancer, the researchers said. The findings did not change when the researchers took into account age, alcohol use, and the use of proton pump inhibitors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »